Procedural Safety and Long term Clinical Outcomes in Patients with coronary artery disease
Not Applicable
- Conditions
- Health Condition 1: I20-I25- Ischemic heart diseases
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients in whom DCB balloon was used during percutaneous coronary intervention who will be willing to give informed consent
Exclusion Criteria
Patients who will not give consent
Patients who could not be contacted
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Procedural success: Angiographic success (30% of residual disease without any major dissection (society of cardiovascular angiography and interventions (SCAI) dissections type D and above) with TIMI 3 flow without any adverse events or bail-out stenting. <br/ ><br>Major adverse cardiac events (MACE) – Death /MI/ reintervention <br/ ><br>Timepoint: 36 months
- Secondary Outcome Measures
Name Time Method Bail-out stenting ( Any stent that was used after DCB at the target is considered as bail-out DCB- Which is failed DCB attempt) <br/ ><br>Death, MI, repeat revascularization, procedural success <br/ ><br>Side branch occlusion in case of bifurcation lesion <br/ ><br>Timepoint: 36 Months